---

$2.58

-0.0156 ( +3.20% ) 10.6K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-07-02	Sale	-11580.00	Watkins Bradley Mitchell
2024-07-02	Sale	-11580.00	Keyser Jane Elizabeth
2024-07-02	Sale	-1183.00	Ferge Kristin A
2024-02-29	Sale	-75000.00	Hannasch Brian
2024-02-14	Sale	-150000.00	Hannasch Brian
2024-01-23	Sale	-40000.00	Hannasch Brian
2023-08-10	Sale	-531548.00	MASIMO CORP

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.